You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 25, 2024

FROVA Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


DrugPatentWatch® Litigation and Generic Entry Outlook for Frova

A generic version of FROVA was approved as frovatriptan succinate by GLENMARK PHARMS LTD on March 11th, 2016.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for FROVA?
  • What are the global sales for FROVA?
  • What is Average Wholesale Price for FROVA?
Summary for FROVA
Drug patent expirations by year for FROVA
Drug Prices for FROVA

See drug prices for FROVA

Paragraph IV (Patent) Challenges for FROVA
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
FROVA Tablets frovatriptan succinate 2.5 mg 021006 1 2011-03-09

US Patents and Regulatory Information for FROVA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Endo Operations FROVA frovatriptan succinate TABLET;ORAL 021006-001 Nov 8, 2001 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Norvium Bioscience FROVATRIPTAN SUCCINATE frovatriptan succinate TABLET;ORAL 202931-001 Aug 28, 2014 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Amneal Pharms Co FROVATRIPTAN SUCCINATE frovatriptan succinate TABLET;ORAL 211292-001 Nov 6, 2018 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Glenmark Pharms Ltd FROVATRIPTAN SUCCINATE frovatriptan succinate TABLET;ORAL 204730-001 Mar 11, 2016 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Renata FROVATRIPTAN SUCCINATE frovatriptan succinate TABLET;ORAL 213891-001 Apr 6, 2022 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for FROVA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Endo Operations FROVA frovatriptan succinate TABLET;ORAL 021006-001 Nov 8, 2001 ⤷  Sign Up ⤷  Sign Up
Endo Operations FROVA frovatriptan succinate TABLET;ORAL 021006-001 Nov 8, 2001 ⤷  Sign Up ⤷  Sign Up
Endo Operations FROVA frovatriptan succinate TABLET;ORAL 021006-001 Nov 8, 2001 ⤷  Sign Up ⤷  Sign Up
Endo Operations FROVA frovatriptan succinate TABLET;ORAL 021006-001 Nov 8, 2001 ⤷  Sign Up ⤷  Sign Up
Endo Operations FROVA frovatriptan succinate TABLET;ORAL 021006-001 Nov 8, 2001 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for FROVA

See the table below for patents covering FROVA around the world.

Country Patent Number Title Estimated Expiration
Poland 171034 ⤷  Sign Up
Portugal 100620 DERIVADOS DE TETRA-HIDROCARBAZOL, SEU USO E PREPARACAO E COMPOSICOES FARMACEUTICAS QUE OS CONTEM ⤷  Sign Up
Czech Republic 9601506 ⤷  Sign Up
Singapore 47877 Use of tetrahydrocarbazone derivatives as 5HT receptor agonists ⤷  Sign Up
Brazil 1100460 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for FROVA

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0591280 C00591280/01 Switzerland ⤷  Sign Up FORMER REPRESENTANTIVE: E. BLUM AND CO. PATENTANWAELTE, CH
0591280 C300103 Netherlands ⤷  Sign Up PRODUCT NAME: FROVATRIPTAN EN FARMACEUTISCH AANVAARDBARE ZOUTEN DAARVAN; NAT. REGISTRATION NO/DATE: RVG 27211RVG 27212 2002190419; FIRST REGISTRATION: NL 24548 20001212
0591280 SPC/GB03/014 United Kingdom ⤷  Sign Up PRODUCT NAME: 3 METHYLAMINO-6-CARBOXAMIDO-1, 2, 3, 4-TETRAHYDROCARBAZOLE ("FROVATRIPTAN") INCLUDING A SALT, SOLVATE OR HYDRATE THEREOF; REGISTERED: FR NL 24548 20001212; UK PL 16239/0017 20021007; UK PL 16239/0018 20021007
0591280 01C0019 France ⤷  Sign Up PRODUCT NAME: FROVATRIPTAN SUCCINATE MONOHYDRATE; NAT. REGISTRATION NO/DATE: NL 24548 20001212; FIRST REGISTRATION: FR - NL 24548 20001212
0591280 37/2002 Austria ⤷  Sign Up PRODUCT NAME: FROVATRIPAN; NAT. REGISTRATION NO/DATE: 1-24487 20020424; FIRST REGISTRATION: FR NL 24548 20001212
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.